CUL4A and cancer: For instance, recently studies showed that CUL4A, whose overexpression is associated with elevated drug sensitivity, is a promising biomarker for several cancers (including breast cancer)24, 25, and here we revealed that CUL4A overexpression in breast cancer is mainly induced by its copy number gain.